$ROIV
Roivant Sciences Ltd. Stock $roiv

$roiv Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000114036123006180 Filed on February 13, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2021 Q4
Revenue	$61.28M	$17.05M	$24.34M
YoY Change	564.43%	-29.95%	323.32%
Cost Of Revenue	$13.13M	$3.586M	$1.384M
YoY Change	2760.13%	159.1%	102.34%
Gross Profit	$48.15M	$13.47M	$22.96M
YoY Change	449.43%	-41.34%	353.16%
Gross Profit Margin	78.58%	78.97%	94.31%
Selling, General & Admin	$600.5M	$168.3M	$115.5M
YoY Change	332.1%	45.64%	86.72%
% of Gross Profit	1247.11%	1249.52%	503.25%
Research & Development	$623.0M	$125.5M	$153.5M
YoY Change	356.07%	-18.19%	-24.13%
% of Gross Profit	1293.74%	932.22%	668.42%
Depreciation & Amortization	$5.953M	$5.151M
YoY Change
% of Gross Profit	12.36%	38.25%
Operating Expenses	$1.223B	$395.1M	$269.0M
YoY Change	343.98%	46.9%	1.83%
Operating Profit	-$1.175B	-$378.1M	-$246.0M
YoY Change	340.52%	53.68%	-5.04%
Interest Expense	-$16.60M	$27.75M	-$39.47M
YoY Change	-77.63%	-170.31%	109.81%
% of Operating Profit
Other Income/Expense, Net	-$62.19M	$19.90M	-$20.55M
YoY Change	-239.76%	-196.81%	-1096.75%
Pretax Income	-$1.225B	-$382.1M	-$306.0M
YoY Change	320.22%	24.84%	10.96%
Income Tax	$5.190M	$2.819M	$38.00K
% Of Pretax Income
Net Earnings	-$1.009B	-$352.0M	-$306.1M
YoY Change	273.63%	15.01%	11.06%
Net Earnings / Revenue	-1646.59%	-2064.36%	-1257.49%
Basic Earnings Per Share		-$0.49	-$0.41
Diluted Earnings Per Share	-$1.41	-$0.49	-$414.4K
COMMON SHARES
Basic Shares Outstanding	758.4M	725.4M	686.6M
Diluted Shares Outstanding		713.3M	686.6M

Balance Sheet

Concept	2023 Q1	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.677B	$1.527B	$2.214B
YoY Change	-18.62%	-31.02%	130421.43%
Cash & Equivalents	$1.677B	$1.527B	$2.214B
Short-Term Investments
Other Short-Term Assets	$121.8M	$118.8M	$61.70M
YoY Change	48.11%	92.53%	21860.35%
Inventory	$2.761M
Prepaid Expenses	$60.83M	$69.51M
Receivables	$30.38M	$27.97M	$8.921M
Other Receivables	$2.356M	$1.487M	$2.627M
Total Short-Term Assets	$1.799B	$1.646B	$2.288B
YoY Change	-16.21%	-28.03%	115580.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$39.09M	$37.30M	$83.29M
YoY Change	50.88%	-55.22%
Goodwill
YoY Change
Intangibles	$144.9M	$146.1M
YoY Change
Long-Term Investments	$304.3M	$272.5M	$398.7M
YoY Change	-6.6%	-31.67%	-2.94%
Other Assets	$49.48M	$46.22M	$29.81M
YoY Change	207.49%	55.05%
Total Long-Term Assets	$591.0M	$556.7M	$511.8M
YoY Change	34.75%	8.77%	24.6%
TOTAL ASSETS
Total Short-Term Assets	$1.799B	$1.646B	$2.288B
Total Long-Term Assets	$591.0M	$556.7M	$511.8M
Total Assets	$2.390B	$2.203B	$2.799B
YoY Change	-7.56%	-21.31%	578.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$37.83M	$48.00M	$24.36M
YoY Change	9.39%	97.06%	11665.44%
Accrued Expenses	$167.1M	$132.4M	$123.9M
YoY Change	31.05%	6.81%	742.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$40.72M	$37.72M
YoY Change
Total Short-Term Liabilities	$272.4M	$244.3M	$160.7M
YoY Change	47.77%	51.98%	976.6%
LONG-TERM LIABILITIES
Long-Term Debt	$375.5M	$375.1M	$204.0M
YoY Change	78.8%	83.85%
Other Long-Term Liabilities	$17.03M	$21.48M	$164.9M
YoY Change	108.14%	-86.97%	235.8%
Total Long-Term Liabilities	$17.03M	$21.48M	$368.9M
YoY Change	108.14%	-94.18%	651.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$272.4M	$244.3M	$160.7M
Total Long-Term Liabilities	$17.03M	$21.48M	$368.9M
Total Liabilities	$782.0M	$775.8M	$933.7M
YoY Change	49.33%	-16.9%	1358.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.800B	-$3.700B
YoY Change	37.5%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.158B	$955.5M	$1.866B
YoY Change
Total Liabilities & Shareholders Equity	$2.390B	$2.203B	$2.799B
YoY Change	-7.56%	-21.31%	578.17%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2021 Q4
OPERATING ACTIVITIES
Net Income	-$1.009B	-$352.0M	-$306.1M
YoY Change	273.63%	15.01%	11.06%
Depreciation, Depletion And Amortization	$5.953M	$5.151M
YoY Change
Cash From Operating Activities	-$179.1M	-$222.6M	-$268.5M
YoY Change	21.44%	-17.1%	13.36%
INVESTING ACTIVITIES
Capital Expenditures	$1.622M	$508.0K	-$6.073M
YoY Change	-125.9%	-108.36%	5575.7%
Acquisitions
YoY Change
Other Investing Activities	$115.2M	-$3.003M	$0.00
YoY Change	20430.3%
Cash From Investing Activities	$113.6M	-$3.511M	-$6.073M
YoY Change	-2091.46%	-42.19%	5575.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	210.3M	154.5M	-8.422M
YoY Change	19557.2%	-1934.42%	-1915.09%
NET CHANGE
Cash From Operating Activities	-179.1M	-222.6M	-268.5M
Cash From Investing Activities	113.6M	-3.511M	-6.073M
Cash From Financing Activities	210.3M	154.5M	-8.422M
Net Change In Cash	144.8M	-71.61M	-283.0M
YoY Change	-195.2%	-74.7%	19.66%
FREE CASH FLOW
Cash From Operating Activities	-$179.1M	-$222.6M	-$268.5M
Capital Expenditures	$1.622M	$508.0K	-$6.073M
Free Cash Flow	-$180.7M	-$223.1M	-$262.4M
YoY Change	27.98%	-14.98%	10.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17052000
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24341000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33904000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	46063000
CY2022Q4	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0
CY2021Q4	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	66472000
CY2022Q4	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	12514000
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	29276000
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.39
	us-gaap	Profit Loss ProfitLoss	-632803000
CY2022Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-8972000
CY2021Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-2393000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	547000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-2287000
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-8972000
CY2021Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2393000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	547000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2287000
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-393868000
CY2021Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-308478000
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1054054000
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-635090000
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-32036000
CY2021Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-21591000
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-78858000
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-57375000
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-361832000
CY2021Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-286887000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-975196000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-577715000
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1173944
	dei	Entity Address Address Line1 EntityAddressAddressLine1	7th Floor
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-384896000
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Address Address Line2 EntityAddressAddressLine2	50 Broadway
	dei	Entity Address City Or Town EntityAddressCityOrTown	London
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	SW1H 0DB
	dei	Entity Address Country EntityAddressCountry	GB
	dei	Country Region CountryRegion	44
	dei	City Area Code CityAreaCode	207
	dei	Local Phone Number LocalPhoneNumber	400 3347
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	758427350
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	22491000
CY2022Q4	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	0
CY2021Q4	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	0
	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	0
	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	443754000
CY2021Q4	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	703054773
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	703054773
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	662268788
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	662268788
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-384896000
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-306085000
	us-gaap	Profit Loss ProfitLoss	-1054601000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2038943000
CY2022Q2	roiv	Issuance Of Subsidiary Common Shares To The Company Value IssuanceOfSubsidiaryCommonSharesToTheCompanyValue	0
CY2022Q2	roiv	Stock Issued During Period Value In Connection With Equity Incentive Plans And Tax Withholding Payments StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansAndTaxWithholdingPayments	8329000
CY2022Q2	roiv	Stock Issued During Period Value Common Shares Related To Settlement Of Transaction Consideration StockIssuedDuringPeriodValueCommonSharesRelatedToSettlementOfTransactionConsideration	0
CY2022Q2	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	72794000
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	5767000
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-353784000
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1755391000
CY2022Q3	roiv	Issuance Of Subsidiary Common Shares To The Company And Capital Contributions To Subsidiaries IssuanceOfSubsidiaryCommonSharesToTheCompanyAndCapitalContributionsToSubsidiaries	0
CY2022Q3	roiv	Stock Issued During Period Value In Connection With Equity Incentive Plans StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlans	0
CY2022Q3	roiv	Stock Issued During Period Common Shares And Other Consideration For Acquisition Value StockIssuedDuringPeriodCommonSharesAndOtherConsiderationForAcquisitionValue	8948000
CY2022Q3	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	61979000
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001635088
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40782
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3752000
	dei	Entity Registrant Name EntityRegistrantName	ROIVANT SCIENCES LTD.
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-315921000
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1514149000
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	94735000
CY2022Q4	roiv	Stock Issued During Period Value In Connection With Equity Incentive Plans And Tax Withholding Payments StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansAndTaxWithholdingPayments	982000
CY2022Q4	roiv	Issuance Of Subsidiary Common Shares To The Company And Capital Contributions To Subsidiaries IssuanceOfSubsidiaryCommonSharesToTheCompanyAndCapitalContributionsToSubsidiaries	0
CY2022Q4	roiv	Issuance Of Subsidiary Common Shares To The Company Value IssuanceOfSubsidiaryCommonSharesToTheCompanyValue	67728000
CY2022Q4	roiv	Stock Issued During Period Value Subsidiary Stock Options Exercised StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised	437000
CY2022Q4	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	292000
CY2022Q4	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	87500000
CY2022Q4	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	57731000
CY2022Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-8972000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1427138000
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2039514000
CY2021Q2	roiv	Issuance Of Subsidiary Warrants Value IssuanceOfSubsidiaryWarrantsValue	2075000
CY2021Q2	roiv	Capital Contributions To Subsidiaries CapitalContributionsToSubsidiaries	0
CY2021Q2	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	19269000
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2439000
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-101078000
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1957341000
CY2021Q3	roiv	Stock Issued During Period Value Common Shares Upon Closing Of Business Combination And Pipe Financing StockIssuedDuringPeriodValueCommonSharesUponClosingOfBusinessCombinationAndPipeFinancing	-129097000
CY2021Q3	roiv	Stock Issued During Period Value Common Shares Related To Settlement Of Transaction Consideration StockIssuedDuringPeriodValueCommonSharesRelatedToSettlementOfTransactionConsideration	0
CY2021Q3	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	70000000
CY2021Q3	roiv	Stock Issued During Period Value Subsidiary Common And Preferred Shares And Cash Contribution To Majority Owned Subsidiaries StockIssuedDuringPeriodValueSubsidiaryCommonAndPreferredSharesAndCashContributionToMajorityOwnedSubsidiaries	0
CY2021Q3	roiv	Adjustments Of Payment Of Subscription Receivable Value AdjustmentsOfPaymentOfSubscriptionReceivableValue	-100000000
CY2021Q3	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	397312000
CY2021Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2247000
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2545000
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-225640000
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2428408000
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	56116000
CY2021Q4	roiv	Capital Contributions To Subsidiaries CapitalContributionsToSubsidiaries	0
CY2021Q4	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	71216000
CY2021Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2393000
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-306085000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2247262000
	us-gaap	Profit Loss ProfitLoss	-1054601000
	us-gaap	Profit Loss ProfitLoss	-632803000
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	87749000
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	78223000
	us-gaap	Share Based Compensation ShareBasedCompensation	192504000
	us-gaap	Share Based Compensation ShareBasedCompensation	487797000
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-53277000
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-14382000
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	443754000
	roiv	Gain Loss On Fair Value Of Debt And Liability Instruments GainLossOnFairValueOfDebtAndLiabilityInstruments	-90032000
	roiv	Gain Loss On Fair Value Of Debt And Liability Instruments GainLossOnFairValueOfDebtAndLiabilityInstruments	-40747000
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	29276000
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0
	roiv	Gain On Termination Of Equity Interest Options GainOnTerminationOfEquityInterestOptions	0
	roiv	Gain On Termination Of Equity Interest Options GainOnTerminationOfEquityInterestOptions	61472000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12904000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4226000
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	6009000
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5404000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	8066000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1161000
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	31037000
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	16064000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2074034000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2141676000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1541037000
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	13970000
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	3693000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5702000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	35576000
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	0
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-50000000
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6814000
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6171000
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-3342000
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-11117000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-664305000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-530260000
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	6706000
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	320170000
	roiv	Milestone Payments MilestonePayments	140136000
	roiv	Milestone Payments MilestonePayments	0
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11068000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11173000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-88000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-157822000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	308997000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	94735000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
	roiv	Proceeds From Business Combination And Pipe Financing ProceedsFromBusinessCombinationAndPIPEFinancing	0
	roiv	Proceeds From Business Combination And Pipe Financing ProceedsFromBusinessCombinationAndPIPEFinancing	213424000
	roiv	Proceeds From Issuance Of Subsidiary Common Shares Net ProceedsFromIssuanceOfSubsidiaryCommonSharesNet	67727000
	roiv	Proceeds From Issuance Of Subsidiary Common Shares Net ProceedsFromIssuanceOfSubsidiaryCommonSharesNet	0
	roiv	Proceeds From Payment Of Subscription Receivable ProceedsFromPaymentOfSubscriptionReceivable	0
	roiv	Proceeds From Payment Of Subscription Receivable ProceedsFromPaymentOfSubscriptionReceivable	100000000
	roiv	Proceeds From Subsidiary Debt Financings Net ProceedsFromSubsidiaryDebtFinancingsNet	159899000
	roiv	Proceeds From Subsidiary Debt Financings Net ProceedsFromSubsidiaryDebtFinancingsNet	36400000
	roiv	Repayment Of Long Term Debt And Convertible Debt By Subsidiary RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary	22108000
	roiv	Repayment Of Long Term Debt And Convertible Debt By Subsidiary RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary	21590000
	roiv	Payment For Offering And Loan Costs PaymentForOfferingAndLoanCosts	2250000
	roiv	Payment For Offering And Loan Costs PaymentForOfferingAndLoanCosts	20265000
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	0
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	2247000
	roiv	Payments Of Taxes For The Repurchase Of Equity PaymentsOfTaxesForTheRepurchaseOfEquity	9442000
	roiv	Payments Of Taxes For The Repurchase Of Equity PaymentsOfTaxesForTheRepurchaseOfEquity	0
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	569000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	289130000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	305722000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-532997000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	84459000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2226135000
	roiv	Common Shares And Other Consideration Issued For Purchase Of Property And Equipment CommonSharesAndOtherConsiderationIssuedForPurchaseOfPropertyAndEquipment	9694000
	roiv	Common Shares And Other Consideration Issued For Purchase Of Property And Equipment CommonSharesAndOtherConsiderationIssuedForPurchaseOfPropertyAndEquipment	0
	roiv	Noncash Other NoncashOther	7063000
	roiv	Noncash Other NoncashOther	4837000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1500000000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3700000000
	us-gaap	Profit Loss ProfitLoss	-1100000000
	us-gaap	Profit Loss ProfitLoss	-632800000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1527437000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2060400000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	3968000
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	3903000
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	9632000
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	9731000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1541037000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2074034000
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y10M24D
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	151488000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5383000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	146105000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2300000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	9200000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9200000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9200000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9200000
CY2022Q4	roiv	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	107000000
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10855000
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	69507000
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	53370000
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	27967000
CY2022Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	3878000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	3968000
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	3903000
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1487000
CY2022Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2854000
CY2022Q4	roiv	Other Of Other Assets Current OtherOfOtherAssetsCurrent	15866000
CY2022Q1	roiv	Other Of Other Assets Current OtherOfOtherAssetsCurrent	22118000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	118795000
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	86123000
CY2022Q4	roiv	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	56327000
CY2022Q1	roiv	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	66188000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	41916000
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	44262000
CY2022Q4	roiv	Accrued Sales Allowances Current AccruedSalesAllowancesCurrent	16426000
CY2022Q1	roiv	Accrued Sales Allowances Current AccruedSalesAllowancesCurrent	0
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	17690000
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	17081000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	132359000
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	127531000
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7796000
CY2022Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10147000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	5637000
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	708000
CY2022Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	877000
CY2022Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	0
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14310000
CY2022Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.007
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.009
CY2021Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0001
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2022Q4	us-gaap	Interest Income Other InterestIncomeOther	10249000
CY2021Q4	us-gaap	Interest Income Other InterestIncomeOther	66000
	us-gaap	Interest Income Other InterestIncomeOther	17900000
	us-gaap	Interest Income Other InterestIncomeOther	199000
CY2022Q4	us-gaap	Interest Expense Other InterestExpenseOther	8446000
CY2021Q4	us-gaap	Interest Expense Other InterestExpenseOther	1501000
	us-gaap	Interest Expense Other InterestExpenseOther	19393000
	us-gaap	Interest Expense Other InterestExpenseOther	5566000
CY2022Q4	roiv	Other Income Expense OtherIncomeExpense	18095000
CY2021Q4	roiv	Other Income Expense OtherIncomeExpense	2464000
	roiv	Other Income Expense OtherIncomeExpense	11060000
	roiv	Other Income Expense OtherIncomeExpense	2838000
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19898000
CY2021Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1029000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9567000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2529000

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001140361-23-006180-index-headers.html	Edgar Link	pending
0001140361-23-006180-index.html	Edgar Link	pending
0001140361-23-006180.txt	Edgar Link	pending
0001140361-23-006180-xbrl.zip	Edgar Link	pending
brhc10047697_10q.htm	Edgar Link	pending
brhc10047697_ex10-1.htm	Edgar Link	pending
brhc10047697_ex10-2.htm	Edgar Link	pending
brhc10047697_ex31-1.htm	Edgar Link	pending
brhc10047697_ex31-2.htm	Edgar Link	pending
brhc10047697_ex32-1.htm	Edgar Link	pending
brhc10047697_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
brhc10047697_10q_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
roiv-20221231.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
roiv-20221231_cal.xml	Edgar Link	unprocessable
roiv-20221231_def.xml	Edgar Link	unprocessable
roiv-20221231_lab.xml	Edgar Link	unprocessable
roiv-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ROIV
Roivant Sciences Ltd. Stock $roiv

2023 Q1 Form 10-Q Financial Statement

#000114036123006180 Filed on February 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ROIV Roivant Sciences Ltd. Stock $roiv

2023 Q1 Form 10-Q Financial Statement

#000114036123006180 Filed on February 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ROIV
Roivant Sciences Ltd. Stock $roiv